InvestorsHub Logo
Followers 0
Posts 142
Boards Moderated 0
Alias Born 05/20/2016

Re: None

Tuesday, 01/29/2019 4:24:27 PM

Tuesday, January 29, 2019 4:24:27 PM

Post# of 233761
https://www.sec.gov/news/press-release/2019-6

CytoDyn Inc. disclosed material weaknesses in each of its Forms 10-K over a period of nine years, from 2008 through 2016. CytoDyn included in its public filings the same, nearly boilerplate, disclosure of material weaknesses for nine consecutive years. CytoDyn remediated its material weaknesses and determined that ICFR was effective as of May 31, 2017. The Commission’s settled order includes violations of Exchange Act Section 13(b)(2)(B) and Rule 13a-15(a), thereunder, and payment of a $35,000 civil penalty
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News